Cargando…

Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.

With the emergence of drug-resistant Streptococcus pneumoniae, community-specific antimicrobial susceptibility patterns have become valuable determinants of empiric therapy for S. pneumoniae infections. Traditionally, these patterns are tracked by active surveillance for invasive disease, collection...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, A E, Hedberg, K, Cieslak, P R, Cassidy, M, Stefonek, K R, Fleming, D W
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627721/
https://www.ncbi.nlm.nih.gov/pubmed/10511525
_version_ 1782163582485528576
author Chin, A E
Hedberg, K
Cieslak, P R
Cassidy, M
Stefonek, K R
Fleming, D W
author_facet Chin, A E
Hedberg, K
Cieslak, P R
Cassidy, M
Stefonek, K R
Fleming, D W
author_sort Chin, A E
collection PubMed
description With the emergence of drug-resistant Streptococcus pneumoniae, community-specific antimicrobial susceptibility patterns have become valuable determinants of empiric therapy for S. pneumoniae infections. Traditionally, these patterns are tracked by active surveillance for invasive disease, collection of isolates, and centralized susceptibility testing. We investigated whether a simpler and less expensive method aggregating existing hospital antibiograms--could provide community-specific antimicrobial susceptibility data. We compared 1996 active surveillance data with antibiogram data from hospital laboratories in Portland, Oregon. Of the 178 S. pneumoniae active surveillance isolates, 153 (86% [95% confidence interval (CI) = 80% to 91%]) were susceptible to penicillin. Of the 1,092 aggregated isolates used by hospitals to generate antibiograms, 921 (84% [95% CI = 82%-87%]) were susceptible to penicillin. With the exception of one hospital's erythromycin susceptibility results, hospital-specific S. pneumoniae susceptibilities to penicillin, cefotaxime, trimethoprim-sulfamethoxazole, and erythromycin from the two methods were statistically comparable. Although yielding fewer data than active surveillance, antibiograms provided accurate, community-specific drug-resistant S. pneumoniae data in Oregon.
format Text
id pubmed-2627721
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-26277212009-05-20 Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method. Chin, A E Hedberg, K Cieslak, P R Cassidy, M Stefonek, K R Fleming, D W Emerg Infect Dis Research Article With the emergence of drug-resistant Streptococcus pneumoniae, community-specific antimicrobial susceptibility patterns have become valuable determinants of empiric therapy for S. pneumoniae infections. Traditionally, these patterns are tracked by active surveillance for invasive disease, collection of isolates, and centralized susceptibility testing. We investigated whether a simpler and less expensive method aggregating existing hospital antibiograms--could provide community-specific antimicrobial susceptibility data. We compared 1996 active surveillance data with antibiogram data from hospital laboratories in Portland, Oregon. Of the 178 S. pneumoniae active surveillance isolates, 153 (86% [95% confidence interval (CI) = 80% to 91%]) were susceptible to penicillin. Of the 1,092 aggregated isolates used by hospitals to generate antibiograms, 921 (84% [95% CI = 82%-87%]) were susceptible to penicillin. With the exception of one hospital's erythromycin susceptibility results, hospital-specific S. pneumoniae susceptibilities to penicillin, cefotaxime, trimethoprim-sulfamethoxazole, and erythromycin from the two methods were statistically comparable. Although yielding fewer data than active surveillance, antibiograms provided accurate, community-specific drug-resistant S. pneumoniae data in Oregon. Centers for Disease Control and Prevention 1999 /pmc/articles/PMC2627721/ /pubmed/10511525 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Article
Chin, A E
Hedberg, K
Cieslak, P R
Cassidy, M
Stefonek, K R
Fleming, D W
Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.
title Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.
title_full Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.
title_fullStr Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.
title_full_unstemmed Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.
title_short Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.
title_sort tracking drug-resistant streptococcus pneumoniae in oregon: an alternative surveillance method.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627721/
https://www.ncbi.nlm.nih.gov/pubmed/10511525
work_keys_str_mv AT chinae trackingdrugresistantstreptococcuspneumoniaeinoregonanalternativesurveillancemethod
AT hedbergk trackingdrugresistantstreptococcuspneumoniaeinoregonanalternativesurveillancemethod
AT cieslakpr trackingdrugresistantstreptococcuspneumoniaeinoregonanalternativesurveillancemethod
AT cassidym trackingdrugresistantstreptococcuspneumoniaeinoregonanalternativesurveillancemethod
AT stefonekkr trackingdrugresistantstreptococcuspneumoniaeinoregonanalternativesurveillancemethod
AT flemingdw trackingdrugresistantstreptococcuspneumoniaeinoregonanalternativesurveillancemethod